Literature DB >> 912867

Specific serum quinidine assay by high-performance liquid chromatography.

W G Crouthamel, B Kowarski, P K Narang.   

Abstract

The cardioactive drug quinidine has a narrow therapeutic index; consequently, determination of serum quinidine concentrations can be important. We describe a relatively rapid and specific assay for quinidine in serum by high-performance liquid chromatography. It is suitable for use in patient monitoring or pharmacodynamic studies. Alkalinized serum is extracted with benzene, which is evaporated under nitrogen and reconstituted with methanol; an aliquot is chromatographed. Quinidine is separated from its metabolites and dihydroquinidine (a contaminant in quinidine raw materials). The retention time for quinidine is 4 min 10 s, for dihydroquinidine it is 5.5 min. Results for patients' sera by this assay method and the double-extraction method of Cramer and Isaksson [Scand. J. Clin. Lab. Invest. 15, 553 (1963] correlate well (r = .975).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912867

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  Drug interferences with plasma assays in therapeutic drug monitoring.

Authors:  S Yosselson-Superstine
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of quinidine.

Authors:  H R Ochs; D J Greenblatt; E Woo
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Absorption of quinidine and dihydroquinidine in humans.

Authors:  D M Hailey; A R Lea; D M Coles; P E Heaume; W J Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.

Authors:  M Chimienti; M B Regazzi; M T La Rovere; J A Salerno; M Previtali; V Montericcio; R Rondanelli; C Montemartini
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.